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Angiotensin II is an important determinant of inward remodeling in cerebral arterioles.
Many of the vascular effects of angiotensin II are mediated by reactive oxygen species
(ROS) generated from homologs of NADPH oxidase with Nox2 predominating in small
arteries and arterioles. Therefore, we tested the hypothesis that superoxide generated by
Nox2 plays a role in angiotensin II-induced cerebral arteriolar remodeling. We examined
Nox2-deficient and wild-type (WT) mice in which a pressor or a non-pressor dose of
angiotensin II (1000 or 200 ng/kg/day) or saline was infused for 4 weeks via osmotic
minipumps. Systolic arterial pressure was measured by a tail-cuff method. Pressure
and diameter of cerebral arterioles were measured through an open cranial window
in anesthetized mice. Cross-sectional area (by histology) and superoxide level (by
hydroethidine staining) of cerebral arterioles were determined ex vivo. The pressor, but
not the non-pressor, dose of angiotensin II significantly increased systolic arterial pressure
in both WT and Nox2-deficient mice. Both doses of angiotensin II increased superoxide
levels and significantly reduced external diameter in maximally dilated cerebral arterioles in
WT mice. Increased superoxide and inward remodeling were prevented in Nox2-deficient
mice. Moreover, only the pressor dose of AngII increased cross-sectional area of arteriolar
wall in WT mice and was prevented in Nox2-deficient mice. In conclusion, superoxide
derived from Nox2-containing NADPH oxidase plays an important role in angiotensin
II-mediated inward remodeling in cerebral arterioles. This effect appears to be independent
of pressure and different from that of hypertrophy.
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INTRODUCTION
Stroke is a common cause of death and disability in devel-
oped countries and it is estimated that about 800,000 people
have stroke each year in the United States (Goldstein et al.,
2011). Chronic hypertension, an important risk factor of stroke,
causes profound changes in cerebral vascular structure, such as
hypertrophy and inward remodeling (Heagerty et al., 1993). To
distinguish it from hypertrophy, we define inward remodeling
as a reduction in external diameter due to rearrangement of
existing components around a smaller lumen that cannot be
accounted for by a reduction in vessel distensibility (Baumbach
and Heistad, 1989). It is generally assumed that hypertrophy and
inward remodeling play a central role in production of, and pro-
tection against, stroke during chronic hypertension (Izzard et al.,
2005).
The renin-angiotensin system plays an important role in reg-
ulating cerebral vascular structure. Angiotensin II (AngII) is
one of several determinants, along with other humoral factors,
sympathetic nerves and increases in arterial pressure per se,
that may result in hypertrophy of cerebral arterioles (Baumbach
et al., 1989, 1991, 2003). In contrast, determinants of cere-
bral arteriolar inward remodeling appear to be limited primarily
to AngII (Chillon and Baumbach, 1999; Didion and Faraci,
2003). Unlike hypertrophy, the molecular mechanisms activated
by AngII that ultimately lead to inward remodeling remain largely
unknown.
Growing evidence suggests that reactive oxygen species (ROS)
generated by the renin-angiotensin system may act as sec-
ond messengers in pathways that lead to vascular changes.
Superoxide scavengers or inhibitors of NADPH oxidase prevent
AngII-induced endothelial dysfunction in the cerebral circula-
tion (Didion and Faraci, 2003). Moreover, increases in ROS due
to a deficiency of superoxide dismutase have been shown to
cause hypertrophy, but not inward remodeling, in cerebral arte-
rioles (Baumbach et al., 2006). We are unaware of any previous
study that directly addresses the role of ROS in the produc-
tion of AngII-induced inward remodeling and hypertrophy in the
cerebral circulation.
AngII stimulates production of superoxide through one or
more of the several known homologs of NADPH oxidase (Cai
et al., 2003). The expression and activity of the NADPH oxidase
homolog, Nox2, is higher in cerebral arteries than in systemic
arteries (Miller et al., 2009). In addition, Nox2 is the predom-
inant NADPH oxidase in smooth muscle derived from small
resistance arteries (Touyz et al., 2002), andAngII-induced impair-
ment of endothelial function and cerebral blood flow is prevented
in Nox2-deficient (−/−) mice (Girouard et al., 2006; Chrissobolis
et al., 2012). These findings suggest that Nox2 may be involved
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in AngII-mediated changes in the cerebral circulation. Therefore,
the aim of this study was to test the hypothesis that deficiency
of Nox2 prevents AngII-induced inward remodeling and hyper-
trophy in cerebral arterioles. To control for the effects of hyper-
tension on cerebral arteriolar structure, we examined effects of a
non-pressor, as well as a pressor, dose of AngII.
MATERIALS AND METHODS
All protocols and procedures conform to the National Institutes
of Health Guide for the Care and Use of Laboratory Animals
and were approved by the Institutional Animal Care and Use
Committee of the University of Iowa.
ANIMALS
Studies were conducted in 3-month-old male and female
Nox2−/− mice (n = 30) and wild-type (WT) littermates
(n = 30). Male-to-female ratio in each experiment and animal
group was 50%. Nox2−/− mice andWT littermates were derived
from heterozygous Nox2−/− mice (Jackson Laboratories, Bar
Harbor, ME, USA). Compared to age-matched WT littermates,
the Nox2−/− strain of mice from the Jackson Laboratories have
similar body weights and normal function of heart and kid-
neys. Breeding and genotyping were performed in a virus- and
pathogen-free barrier facility at the University of Iowa.
ANGIOTENSIN II TREATMENT ANDMEASUREMENT OF CONSCIOUS
BLOOD PRESSURE
Osmotic minipumps (Alzet, model 1004, Durect, Cupertino,
CA, USA) were implanted subcutaneously in the midscapu-
lar region in mice during anesthesia with ketamine/xylazine
(87.5/12.5mg/mL, 10ml/kg, i.p.). The minipumps were used to
continuously infuse vehicle (isotonic saline) or AngII (1000 or
200 ng/kg/min) for a period of 28 days.
Systolic blood pressure (BP) wasmeasured using an automated
tail-cuff device (BP-2000, Visitech Systems). Prior to implanta-
tion of minipumps, mice were trained for 5 days and baseline BP
was recorded, followed by minipump implantation and measure-
ments of BP on day 7, 14, 21, and 28 of AngII treatment. Each day
thirty BPmeasurements were made for each mouse and data were
averaged.
MEASUREMENT OF CEREBRAL ARTERIOLAR PRESSURE AND
DIAMETER
Animals were weighed and anesthetized with ketamine/xylazine
(87.5/12.5mg/ml, 10ml/kg, i.p.). Supplementary anesthetic (pen-
tobarbital sodium, 50mg/ml) was given during the experiment
through a catheter connected to the femoral vein. Systemic sys-
tolic, diastolic, mean, and pulse pressure were measured con-
tinuously via catheter connected to femoral arteries. The depth
of anesthesia was assessed every 15min by toe pinch. Pressure
and internal diameter were measured in first-order cerebral
arterioles on the cerebrum through an open cranial window
in vivo (Baumbach et al., 2003). Cerebral arteriolar systolic, dias-
tolic, mean, and pulse pressure were measured continuously
with a glass micropipette connected to a servo-null pressure-
measuring device (model 5, Instrumentation for Physiology
and Medicine, Inc.). Approximately 30min after completion of
surgery, measurements of cerebral arterioles were obtained under
baseline conditions. To evaluate passive characteristics of cere-
bral arterioles, vascular muscle was deactivated by suffusion
of cerebral vessels with artificial cerebrospinal fluid contain-
ing EDTA (67mmol/L), which produces maximal dilatation of
cerebral arterioles (Baumbach et al., 1988). Pressure-internal
diameter relationships were obtained in maximally dilated arte-
rioles between arteriolar mean pressures of 40 and 10mmHg
by stepwise controlled hemorrhage through a catheter con-
nected to the femoral vein. Internal diameter of arterioles was
continuously recorded through a microscope connected to a
closed-circuit video system with a final magnification of ×356.
Internal diameter was measured from digitized images of arte-
rioles using Image J (National Institute of Health, Bethesda,
MD, USA).
MEASUREMENT OF CEREBRAL ARTERIOLAR CROSS-SECTIONAL AREA
To evaluate cross-sectional area (CSA) of the arteriolar wall,
arterioles were fixed at physiological pressure in vivo by suffu-
sion of vessels with fixative (2.25% glutaraldehyde in 0.10 mol/L
cacodylate buffer) while maintaining cerebral arteriolar pressure
at physiological levels the same as before stepwise hemorrhage.
After the anesthetized animal was euthanized using overdose
sodium pentobarbital, a cerebral arteriolar segment was removed,
processed, and embedded in Spurr’s low viscosity resin while
maintaining cross-sectional orientation. Samples were cut into
1-μm sections, stained with Richerson’s stain and CSA was deter-
mined histologically by Image J. CSA of the cerebral arteriolar
wall was determined by tracing the inner and outer edges of
the vessel wall using Image J, which yielded lumen area (CSAL)
and the area of the vessel wall plus the lumen area (CSAW+L).
CSA of the vessel wall was calculated by subtracting CSAL from
CSAW+L. A key advantage of this method is that tissue volume
is well preserved (Lee et al., 1980) as compared to fixation with
formaldehyde and paraffin embedding (Hart and O’Donnell,
1980), which typically results in a 20–30% shrinkage in tis-
sue volume. Another advantage is that the 1-μm thick plastic
embedded sections increase accuracy in CSA measurements by
providing a higher resolution of light microscopic detail than sec-
tions of paraffin embedded tissue, which are typically 5–6μm in
thickness.
MEASUREMENT OF SUPEROXIDE
Levels of superoxide were evaluated in 6–8μm thick frozen sec-
tions of unfixed cerebral arterioles using hydroethidine-based
(2μmol/L hydroethidine) confocal microscopy as described pre-
viously (Didion et al., 2002). Laser settings were identical for
acquisition of images, and vessels from WT and Nox2−/− mice
were processed and imaged in parallel. Relative increases in ethid-
ium fluorescence were determined and normalized to the CSA of
the vessel wall.
CALCULATION OF MECHANICAL CHARACTERISTICS
The methods that we used to calculate circumferential stress
and strain of arterioles on the surface of the cerebrum
have been described in detail (Chillon and Baumbach, 2004).
Circumferential stress (σ) was calculated from cerebral arteriolar
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pressure (P), internal diameter of cerebral arterioles (Di), and
wall thickness (WTh): σ = (P × Di)/(2WTh). Cerebral arteriolar
pressure was converted from mmHg to newtons/m2 (1mmHg =
1.334 × 102 N/m2). WTh was calculated from histological mea-
surements of CSA and in vivo measurements of Di: WTh =
[(4CSA/π + Di2)1/2 – Di]/2. External diameter of cerebral arte-
rioles (De) is calculated as: De = Di + 2WT. Histological deter-
minations of CSA were used in all calculations of WTh and
circumferential stress. Circumferential strain (ε) was calculated as
ε = (Di − Do)/Do, where Do was original diameter. We defined
original diameter as the diameter at 10mmHg pressure. Elastic
modulus (λ) was defined as the slope of the stress-strain curve
and calculated as σ/ε.
STATISTICAL ANALYSIS
All data are presented as mean ± SEM. Differences between
individual groups were determined by ANOVA with post-hoc
Bonferroni test, using Graph Pad Prism 5 (Graph Pad Software,
Inc., San Diego, CA, USA). Differences were considered signifi-
cant when P < 0.05.
RESULTS
NOX2 DEFICIENCY DOES NOT ALTER PRESSOR RESPONSES OF
ANGIOTENSIN II
Pretreatment levels of systolic arterial BP (SBP) were not signifi-
cantly different in WT and Nox2−/− mice (Table 1). Treatment
with saline or the non-pressor dose of AngII had no effect on
SBP in either WT or Nox2−/− mice. The pressor dose of AngII,
as expected, significantly increased SBP in WT and Nox2−/−
mice 7 days after the initiation of treatment. SBP remained sig-
nificantly elevated in both WT and Nox2−/− mice during the
subsequent 3 weeks of treatment with the pressor dose of AngII.
Thus, deficiency of Nox2 did not alter the pressor response to
AngII.
NOX2 DEFICIENCY PREVENTS ANGIOTENSIN II-MEDIATED
SUPEROXIDE PRODUCTION
Figure 1 shows representative micrographs and quantifica-
tion of ethidium fluorescence in cerebral arterioles (Figure 1).
Quantification of ethidium signal revealed basal levels of superox-
ide to be similar in cerebral arterioles of saline-treated Nox2−/−
mice and WT mice. Ethidium signal was significantly higher in
cerebral arterioles in WT mice treated with both the non-pressor
and pressor doses of AngII. In addition, the pressor dose of
AngII increased relative fluorescent intensity inWTmice by about
100%, while the non-pressor dose increased intensity by about
50%. In contrast to WT mice, cerebral arteriolar fluorescence was
unchanged during treatment of Nox2−/− mice with either dose
of AngII relative to Nox2−/− mice treated with saline.
NOX2 DEFICIENCY PREVENTS CHANGES OF CEREBRAL ARTERIOLAR
STRUCTURE BY ANGIOTENSIN II
Internal and external diameters in maximally dilated cerebral
arterioles were not significantly different in saline-treatedWT and
Nox2−/− mice. Both internal and external diameters were signif-
icantly decreased by the pressor, as well as the non-pressor, dose of
Table 1 | Physiological data.
Parameters WT WT WT −/− −/− −/−
Saline AII-1000 AII-200 Saline AII-1000 AII-200
Systolic Arterial
Pressure (mmHg)
Day 0 110 ± 4 115 ± 3 109 ± 4 116 ± 4 104 ± 3 107 ± 4
Day 7 106 ± 3 135 ± 5* 111 ± 3 110 ± 5 142 ± 8* 109 ± 6
Day 14 112 ± 3 134 ± 3* 115 ± 4 109 ± 5 139 ± 4* 109 ± 5
Day 28 116 ± 4 128 ± 4* 112 ± 4 113 ± 4 133 ± 5* 112 ± 3
Cerebral Arterioles
Pressure (mmHg)
Systolic 49 ± 4 47 ± 3 57 ± 2 48 ± 4 46 ± 4 53 ± 2
Diastolic 34 ± 3 34 ± 2 41 ± 1 34 ± 3 35 ± 3 39 ± 2
Mean 39 ± 3 38 ± 3 46 ± 1 39 ± 3 39 ± 4 44 ± 2
Pulse 15 ± 1 13 ± 1 16 ± 1 14 ± 1 11 ± 1 14 ± 1
Elastic Modulus 6.7 ± 0.7 5.1 ± 0.4* 6.9 ± 0.3 6.7 ± 0.8 5.9 ± 0.5 6.3 ± 0.6
Arterial Blood Gases
pH 7.35 ± 0.04 7.34 ± 0.02 7.38 ± 0.02 7.38 ± 0.03 7.39 ± 0.02 7.35 ± 0.02
pCO2 30 ± 4 33 ± 2 28 ± 1 24 ± 2 29 ± 2 32 ± 2
pO2 112 ± 7 99 ± 4 107 ± 5 113 ± 9 105 ± 8 94 ± 4
Age (week) 16.6 ± 0.9 17.8 ± 0.8 17.6 ± 1.0 17.4 ± 0.9 18.5 ± 0.8 17.9 ± 0.9
Weight (g) 26.1 ± 1.3 26.4 ± 2.0 26.8 ± 1.3 24.5 ± 1.0 23.8 ± 1.5 25.8 ± 0.9
n 10 10 10 10 10 10
Systolic arterial pressure, cerebral arteriolar pressure, internal diameters, elastic modulus, and arterial blood gases in wild-type (WT) and Nox2 deficient (−/−) mice
treated with angiotensin II (AII, 200 or 1000ng/kg/min). Systolic arterial pressure was measured using the tail-cuff method in conscious mice. Cerebral arteriolar
pressure was measured under anesthetized condition. Values are mean ± SEM.
*P < 0.05 vs. WT saline group.
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FIGURE 1 | Representative confocal fluorescent sections (inner and outer
edges of cerebral arterioles are highlighted) and relative fluorescence in
cerebral arterioles in wild-type (WT) and Nox2-deficient (−/−) mice
treated with a pressor (AngII-1000) or a non-pressor (AngII-200) dose of
angiotensin II or saline. Data are presented as mean ± SEM of 5–6 mice.
∗P < 0.05 vs. saline-treatedWT group; †P < 0.05 vs. correspondingWT group.
AngII at all levels of arteriolar pressure between 10 and 40mmHg
in WT mice (Figure 2). In Nox2−/− mice, on the other hand,
internal and external diameters were not significantly different
in either of the AngII treated groups than in the saline treated
group at any level of arteriolar pressure. Therefore, these results
showed that Nox2 deficiency prevented AngII-induced inward
remodeling in cerebral arterioles.
CSA of the cerebral arteriolar wall was significantly increased
in pressor, but not the non-pressor, dose of AngII in WT mice
(Figure 3). In contrast, neither dose of AngII significantly altered
CSA of the arteriolar wall in Nox2−/− mice. This finding indi-
cates that deficiency of Nox2 prevented AngII-induced hypertro-
phy of cerebral arterioles.
The stress-strain curve in cerebral arterioles treated with the
pressor, but not the non-pressor, dose of AngII was shifted to
the right in arterioles treated with saline in WT mice (Figure 4).
The slope of tangential elastic modulus vs. stress was decreased
in cerebral arterioles in the pressor AngII group relative to the
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FIGURE 2 | Pressure-internal and external diameter relationships in
maximally dilated cerebral arterioles in wild-type (WT) or
Nox2-deficient (−/−) mice treated with a pressor (AII-1000) or
a non-pressor (AII-200) dose of angiotensin II or saline. Data
are presented as mean ± SEM of 10 mice. ∗P < 0.05 vs.
saline-treated WT group.
non-pressor AngII and saline group (Table 1). In Nox2−/− mice,
the stress-strain curves in cerebral arterioles treated with both
the pressor and non-pressor doses of AngII were shifted to the
right of the curve in arterioles treated with saline, but to a
lesser degree than observed in WT mice (Figure 4). The slope
of tangential elastic modulus vs. stress was not significantly dif-
ferent in either the pressor or non-pressor group relative to the
saline group (Table 1). These findings suggest that deficiency of
Nox2 may attenuate AngII-induced increases in distensibility of
cerebral arterioles.
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FIGURE 3 | Representative micrographs of histological sections and
cross-sectional area (CSA) of maximally dilated cerebral arterioles
in wild-type (WT) and Nox2-deficient (−/−) mice treated with a
pressor (AngII-1000) or a non-pressor (AngII-200) dose of
angiotensin II or saline. Data are presented as mean ± SEM of 10
mice. ∗P < 0.05 vs. saline-treated WT group; †P < 0.05 vs.
AngII-treated WT group. ED, external diameter; ID, internal diameters;
WT, wall thickness.
DISCUSSION
There are several major new findings in this study. First, both
the non-pressor and pressor doses of AngII increased superox-
ide levels in cerebral arterioles in WT, but not in Nox2−/−
mice. Increases in cerebral arteriolar superoxide in WT mice
were greater with the pressor dose of AngII than with the non-
pressor dose. Second, the non-pressor dose of AngII caused
inward remodeling of cerebral arterioles in WT mice that was
prevented in Nox2−/− mice. These results suggest that Nox2-
derived superoxide, independent of increase in pressure, has an
important role in AngII-mediated inward remodeling. Third,
the mechanism of AngII-mediated inward remodeling of cere-
bral arterioles appears to be different from that of hypertrophy.
Only the pressor dose of AngII resulted in hypertrophy of cere-
bral arterioles, suggesting pressor effect may be mandatory for
hypertrophy. Together, we showed that AngII-induced superoxide
production from Nox2-containing NADPH oxidase has impor-
tant role in inward remodeling, which is mechanistically different
from that of hypertrophy.
AngII stimulates production of ROS in the vessel wall via acti-
vation of membrane-bound NADPH oxidases. The distribution
of NADPH oxidase homologs Nox1, Nox2, and Nox4 appears
to be dependent on cell type and vessel size. Nox1 is the pre-
dominant NADPH oxidase homolog in smooth muscle derived
from large arteries (Lassegue et al., 2001), whereas Nox2 predom-
inates in smooth muscle derived from small resistance arteries
(Touyz et al., 2002). In this study, we used ethidium fluorescence
to show that AngII stimulates superoxide production in cerebral
arterioles through activation of Nox2. This finding supports the
concept that Nox2 is the predominant source of superoxide in
arterioles in the cerebral circulation. We are aware of the potential
problems inherent in using ethidium staining as an indicator of
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FIGURE 4 | Stress-strain relationships in maximally dilated cerebral arterioles in wild-type (WT) and Nox2-deficient (−/−) mice treated with a pressor
(AII-1000) or a non-pressor (AII-200) dose of angiotensin II or saline. Data are presented as mean ± SEM of 10 mice.
superoxide production, such as the introduction of non-specific
fluorescent products. To address these concerns, we kept all con-
ditions of staining and settings of confocal microscopy consistent
for all samples and compared staining density between groups
semi-quantitatively.
Production of ROS derived from NADPH oxidase plays an
important role in AngII-induced hypertension (Ortiz et al., 2001).
It is clear that Nox1 enhances pressor effects of AngII (Dikalova
et al., 2005; Gavazzi et al., 2006). On the other hand, the contri-
bution of Nox2-generated superoxide to AngII-induced increases
in BP remains debatable. Previous studies found that Nox2 defi-
ciency either diminishes (Wang et al., 2001) or has no effect
(Touyz et al., 2005) on the pressor response to AngII. Our find-
ing in this study supports the concept that Nox2 has no significant
effect on AngII-induced hypertension.Moreover, the non-pressor
dose of AngII did not increase BP, although a significant increase
in superoxide was detected. In contrast to our finding, the same
dose of AngII that did not produce a pressor response in this
study has been reported to slightly increase BP (about 10%)
after 3 weeks in at least two previous studies (Kawada et al.,
2002; Izumiya et al., 2003). We speculate the difference may be
due to different mouse colonies from different animal providers.
For example, inbred C57/B6 mice from Taconic Laboratories
(Germantown, NY, USA) were used in a previous study (Kawada
et al., 2002) vs. inbred Nox2mice that have C57/BL6J background
from Jackson Laboratories.
Inward remodeling of small arteries and arterioles is thought
to be an adaptive response to hypertension that normalizes
wall stress and thus protects against the damaging effects of
elevated pressure (Izzard et al., 2005). The renin-angiotensin
system has been identified as an important determinant of
inward remodeling, as evidenced by the findings that treat-
ment with an angiotensin-converting enzyme inhibitor attenuates
cerebral arteriolar inward remodeling (Chillon and Baumbach,
1999), and overexpression of human renin and angiotensino-
gen results in inward remodeling of cerebral arterioles in mice
(Baumbach et al., 2003). Furthermore, the importance of the
renin-angiotensin system to vascular inward remodeling has been
confirmed in human essential hypertension (Thybo et al., 1995).
Our findings in this study provide additional confirmation of
the important role of AngII in inward remodeling of cerebral
arterioles.
Superoxide derived from NADPH oxidase has been shown
to mediate many of the effects induced by AngII (Griendling
et al., 1994; Rajagopalan et al., 1996; Ushio-Fukai et al., 1999).
A major goal of this study was to examine the role of ROS in
AngII-induced remodeling. Our finding that deficiency of Nox2
prevented AngII-induced inward remodeling in cerebral arteri-
oles suggests that ROS derived from Nox2-containing NADPH
oxidase may act as an important mediator in inward remodel-
ing. In addition, this result corroborates the finding in a previous
study showing that ROS is involved in inward remodeling of sys-
temic resistance arteries (Martinez-Lemus et al., 2011). We spec-
ulate that ROS may promote AngII-induced inward remodeling
of cerebral arterioles through mechanisms that modulate migra-
tion of vascular smooth muscle (VSM). This possibility is based
on the observations that AngII is an important promoter of VSM
migration (Bell and Madri, 1990), and ROS play an important
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role in several signaling domains involved in cellular migration
(San Martin and Griendling, 2010). As an example, nitric oxide
(NO) has been found to inhibit AngII-induced migration of VSM
in vitro (Dubey et al., 1995), which suggests the possibility that
generation of superoxide by AngII may lead to inward remodel-
ing by destroying NO thereby removing its inhibitory influence
on VSMmigration.
Another goal in the present study was to separate pressor and
non-pressor effects of AngII on cerebral arteriolar remodeling.
The possibility that AngII might contribute directly to inward
remodeling independently of its pressor effects was suggested
by our previous findings that (1) a low dose of an angiotensin
converting enzyme inhibitor, perindopril, was nearly as effective
as the high dose in attenuating inward remodeling of cerebral
arterioles in stroke-prone spontaneous hypertensive rats, even
though the low dose was half as effective as the high dose in
lowering cerebral arteriolar pressure, and (2) in contrast to the
low dose of perindopril, the β-blocker, propranolol, did not sig-
nificantly attenuate inward remodeling of cerebral arterioles in
stroke-prone spontaneous hypertensive rats, even though it was
much more effective than the low dose of perindopril in lowering
cerebral arteriolar pressure (Chillon and Baumbach, 1999). Our
finding in this study that the non-pressor dose of AngII resulted
in the same degree of inward remodeling in cerebral arterioles as
the pressor dose provides strong support for the hypothesis that
AngII induces inward remodeling directly, and independently, of
its pressor effect.
Themechanism responsible for AngII-induced hypertrophy of
cerebral arterioles appears to differ from that of AngII-induced
inward remodeling, as suggested by the finding that the non-
pressor dose of AngII did not result in cerebral arteriolar hyper-
trophy, but was sufficient to induce inward remodeling. This
finding suggests that in contrast to inward remodeling, increased
pressure, rather than AngII per se, is an important determinant
of cerebral arteriolar hypertrophy. This concept is arguable, how-
ever, because suppression of the pressor effect of AngII may
or may not prevent vascular hypertrophy (Griffin et al., 1991;
Chillon and Baumbach, 1999). In addition, AngII-induced hyper-
trophy is ROS-dependent, as suggested by the result that defi-
ciency of Nox2 prevented hypertrophy of cerebral arterioles in
response to AngII. This result also supports the concept that Nox2
is the predominant NADPH oxidase responsible for producing
ROS and plays an important role in Ang II-induced hypertrophy
of cerebral arterioles.
In conclusion, we showed for the first time that superoxide
derived from Nox2-containing NADPH oxidase has critical role
in inward remodeling of cerebral arterioles mediated by AngII.
This effect is independent of increases in pressure and appears to
differ from that of hypertrophy.
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